DYNAMX MEDICAL
DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.
DYNAMX MEDICAL
Social Links:
Industry:
Biopharma Biotechnology Health Care Life Science Medical Medical Device
Founded:
2015-03-23
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.dynamxmedical.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.97 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Nginx Amazon Apple Mobile Web App Capable CloudFront Ubuntu OpenResty
Similar Organizations
Fen EP Limited
Fen EP Limited is a developer of biomedical device created to prevent sudden cardiac death.
Lindhe Xtend
Lindhe Xtend has develops and sells user-friendly and flexible prostheses and accessories.
Founder
Investors List
Wild Blue Cohort
Wild Blue Cohort investment in Seed Round - DynamX Medical
Angel Academe
Angel Academe investment in Seed Round - DynamX Medical
Angels in MedCity
Angels in MedCity investment in Seed Round - DynamX Medical
London Co-Investment Fund
London Co-Investment Fund investment in Seed Round - DynamX Medical
Deepbridge Capital
Deepbridge Capital investment in Seed Round - DynamX Medical
Pitch@Palace
Pitch@Palace investment in Non Equity Assistance - DynamX Medical
SBRI Healthcare
SBRI Healthcare investment in Grant - DynamX Medical
Innovate UK
Innovate UK investment in Grant - DynamX Medical
Newest Events participated
Participated in Angels in MedCity Pitching Event Nov-2016
on 2016-11-10 as exhibitor
Participated in Pitch@Palace 5.0
on 2016-03-07 as exhibitor
Official Site Inspections
http://www.dynamxmedical.com
- Host name: ec2-44-206-208-86.compute-1.amazonaws.com
- IP address: 44.206.208.86
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "DynamX Medical"
DynamX Medical - Company Profile - Tracxn
Dec 5, 2024 DynamX Medical - Provider of a biopsy screening medical device targeting cancer and other diseases. Raised a total funding of $3.4M over 2 rounds from 2 investors. Founded …See details»
DynamX Medical Company Profile 2024: Valuation, Funding
DynamX Medical General Information Description. Provider of a medical software intended to offer novel technology to streamline disease diagnosis. The company's software increases the …See details»
DynamX Medical - Crunchbase Company Profile & Funding
Contact Email [email protected] DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated …See details»
DynamX Medical - Company Profile & Staff Directory - ContactOut
DynamX Medical | 106 followers on LinkedIn | DynamX Medical is the new name for BeamLine Diagnostics. At DynamX our vision is to make cancer and disease screening accessible and …See details»
DynamX Medical Overview | SignalHire Company Profile
DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.See details»
DynamX Medical Ltd | VCINVEST DATA - w.pseps.com
Company type Developer of a biopsy triaging system that aims to identify healthy and benign tissue specimens with high accuracy within seconds.See details»
DynamX Medical - Founders and Board of Directors - Tracxn
Oct 22, 2024 DynamX Medical founders & board of directors. Provider of a biopsy screening medical device targeting cancer and other diseases. 2015 • Didcot (United Kingdom) • SeedSee details»
S1E6 - DynamX’s Beeline to Bedside Biopsy Triage
Introduction. Meet Liberty Foreman, PhD. Liberty is Co-founder and CEO of DynamX Medical (FKA BeamLine Diagnostics), a London-based oncology diagnostics start-up that is …See details»
DynamX Medical - CoBee Company Profile & Funding Rounds
Dynamxmedical.com DynamX Medical. DynamX Medical has developed a diagnostic system for cancer and pre-cancer. Business Model: Revenue: $0. Employees: 1-10. Rankings # 721 in …See details»
DynamX Medical: Making Cancer and Disease Screening …
Feb 15, 2019 Back at the beginning of 2017 BeamLine Diagnostics, now trading as DynamX Medical took part in the Greenlight Programme here at Capital…See details»
Dyna Medical Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Dyna Medical Corporation of London, ON. Get the latest business insights from Dun & Bradstreet.See details»
DynamX Company Profile - MedTech Innovator
Value: Pathology is vital to cancer diagnostics and treatment but services are on the verge of collapse due to increasing demand, an aging workforce, and lack of trainees.Consequently, …See details»
Dynamedics Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Dynamedics Corporation of London, ON. Get the latest business insights from Dun & Bradstreet.See details»
Synex Medical Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Synex Medical Inc of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
DynamX Coronary Bioadaptor Breakthrough Designation - Elixir …
MILPITAS, Calif. – June 18, 2024 – Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced the company’s novel bioadaptive implant, DynamX …See details»
Synex Medical Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Synex Medical. Use the PitchBook Platform to explore the full profile.See details»
Elixir Medical’s DynamX Sirolimus-Eluting Coronary Bioadaptor …
MILPITAS, Calif., June 18, 2024--Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced the company’s novel bioadaptive implant, DynamX ...See details»
Japan Regulatory Approval for DynamX - Elixir Medical
MILPITAS, Calif. – October 4, 2023 – Elixir Medical, a developer of disruptive cardiovascular technologies, announced submission to Japan’s Pharmaceutical and Medical Device Agency …See details»
Elixir Medical’s DynamX Sirolimus-Eluting coronary bioadaptor …
Jul 29, 2024 Elixir Medical's DynamX Sirolimus-Eluting Coronary Bioadaptor System Granted FDA Breakthrough Device Designation for the Treatment of Symptomatic Ischemic Heart …See details»
Elixir Medical Announces Outstanding 24-month Data for DynamX …
Jan 27, 2021 Elixir Medical announces strong 24-month safety results for DynamX Biodaptor, a metallic stent-like device that adapts to vessel physiology.See details»